This year the Innovation in Vesicles and Cells for Application in Therapy (IVECAT) has published a protocol for Size-Exclusion Chromatography for separating extracellular vesicles from different biological fluids and a review of the current techniques available.
At the IGTP TODAY
New financing from the Catalan NF2 Patients Association for Research into personalized medicine for Neurofibromatosis Type 2
Can Ruti has been awarded a research project by the Spanish Federation for Rare Diseases (FEDER) Foundation in their fourth call for research projects. The winning project, led by Dr Ignacio Blanco and Dr Elisabeth Castellanos, from the Germans Trias I Pujol Hospital and Institute respectively, is one of five financed by the foundation this year. The research will focus personalized attention for Neurofibromatosis type 2 (NF2) patients to optimize evaluation of their quality of life and refine their classification during diagnosis.
A new heat therapy belt designed at the Germans Trias Hospital to reduce pain during birth is now available
The belt, designed by a midwife at the Germans Trias Hospital, applies heat to the lumbar and suprapubic region, where the pain of contractions is strongest and allows the wearer to move about freely. The project included a clinical trial with 134 women participating, run by Laura Tarrats, who has been able to carry out the work thanks to the support of a Germans Trias Sapiens Award.
Elisa Martró, leader of the Clinical Virology and New Diagnostic Approaches Research Group at the Microbiology Service of the Germans Trias i Pujol Hospital, has been awarded with one of the five projects granted in the First Edition of the Gilead projects for Micro-elimination of Hepatitis C in Spain and evaluated by the Spanish Liver Research Association (AEEH).
In an in vitro study researchers have shown how the nanoparticles are more effective than antibiotics alone. In the future, the nanoparticles will be administered orally as a non-invasive treatment that is much more acceptable to patients.
The IGTP and the Germans Trias Hospital face the spotlight for rare diseases again. This year our professionals are joining World Rare Disease Day on the last day of February to highlight these diseases and shine a light on the research activities in the field on campus.
The Cellular and Molecular Neurobiology Research Group, led by Teresa Gasull at the IGTP has a mission to carry out basic and translational research into strokes. This week they have published a review of recent advances in the field, which includes the role of the ferroptosis in stroke-induced neurodegeneration and includes references to their own recent publications in the field.
On Friday a very special crowd-funding project got underway to support cancer research at Can Ruti. Sales of the book, which describes the experiences of a colon cancer patient in his own words, will be donated to research into the illness carried out by the IGTP Group led by Eva Martínez-Balibrea.
The Digestive Inflammatory Pathology Research Group awarded the prize for best research project at the Catalan Digestive Medicine Conference
A study by the Digestive Inflammatory Pathology Research Group at the IGTP was awarded the best basic-translational research study in the Catalan Digestive Medicine Conference 2019. The study presented by Dr Violeta Lorén is within one of the main research lines of the group and centres on understanding, predicting and solving one of the main complications arising from therapy for patients with ulcerative colitis: the failure of glucocorticoid treatment.
Induced pluripotent stem cells have been generated for the first time from tumor cells in order to study therapies for tumors developed in patients with hereditary diseases with predisposition to cancer
The study, by the Hereditary Cancer research group at the IGTP, focuses on characterizing induced pluripotent stem cells (iPSCs) from benign tumors, characteristic of Neurofibromatosis type 1 (NF1). The iPSCs are able to regenerate indefinitely and give rise to any other cell in the body so they represent an inexhaustible supply of cells to study tumors and new treatments.